Treatments & Techniques
A major trial demonstrated the glucose-lowering drug empagliflozin reduces cardiovascular morbidity and mortality in individuals with Type 2 diabetes and existing cardiovascular disease. Clinicians and researchers discuss how it does so and who is most likely to benefit.
Results of a phase 1b clinical trial published in Nature reveal scientists may be one step closer to finding a treatment that safely impedes the biological progression of Alzheimer’s disease.
Rated one of the nation’s top physicians for patient satisfaction in 2015, Gregory Lowe, MD, urologic surgeon and sexual medicine specialist at OhioHealth Urology Physicians, merges high-level expertise with state-of-the-art devices and techniques to treat erectile dysfunction (ED) and male urinary incontinence (UI).
A 2012 initiative that Cherokee Nation Health Services (CNHS) in Oklahoma launched to enhance hepatitis C management has yielded significant, positive results among the American Indian population.
Researchers assessing the role that venom plays in activating nerve fibers involved in pain sensation have uncovered a surprising mechanism that may influence irritable bowel syndrome (IBS)-related pain.
Not all plant-based foods provide equal benefit in terms of reducing risk of diabetes, a new Harvard study finds.
New research that suggests high cholesterol is inversely related to colorectal cancer risk has implications for statin use.
Using a combination of probiotics, researchers in Slovenia were able to significantly reduce the incidence of late-onset sepsis in a group of preterm infants born with very low birth weights.
Research has demonstrated that minimizing injection-site discomfort increases patient satisfaction, which can have a bearing on provider reimbursement.
Medical technology firm Becton, Dickinson and Company (BD) recently won FDA...
Melanoma patients frequently lack the knowledge or confidence to perform regular, effective skin self-exams (SSEs), according to recent research.
- 1 of 21
- next ›